Learn more

GRAPE KING BIO LTD

Overview
  • Total Patents
    96
  • GoodIP Patent Rank
    14,989
  • Filing trend
    ⇧ 80.0%
About

GRAPE KING BIO LTD has a total of 96 patent applications. It increased the IP activity by 80.0%. Its first patent ever was published in 2014. It filed its patents most often in Taiwan, China and United States. Its main competitors in its focus markets foods and drinks, pharmaceuticals and biotechnology are CELL BIOTECH CO LTD, EROMLIFE CO LTD and HONGRIM TRADING CO LTD.

Patent filings in countries

World map showing GRAPE KING BIO LTDs patent filings in countries

Patent filings per year

Chart showing GRAPE KING BIO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Chen Chin-Chu 73
#2 Chen Yen-Po 42
#3 Chen Yen-Lien 33
#4 Lee Li-Ya 30
#5 Shih Yang-Tzu 30
#6 Jiang Jia-Lin 28
#7 Wang Ci-Sian 28
#8 Lin Shin-Wei 28
#9 Hou Yu-Hsin 28
#10 Lin Ching-Wen 26

Latest patents

Publication Filing date Title
TWI715177B A lactobacillus rhamnosus gklc1, a composition and its use for improving alcoholic injury in liver, stomach and/or intestine
TW202035677A Method for manufacturing and the use of paecilomyces hepiali mycelia active substance for preventing and/or ameliorating acute lung injury
TW202027756A Use of preparing a pharmaceutical composition for improving myelination of central nervous system by hericium erinaceus mycelia extract
TW202026008A Method for manufacturing and the use of lignosus rhinocerus mycelia active substance for preventing and/or ameliorating lung injury
TW202024331A Method of manufacturing and the use of cordyceps cicadae mycelia active substance for preventing and/or improving acute lung injury
TW202019449A Lactobacillus fermentumgkf3, composition containing the same and its use for improving psychataxia
TW202017584A Composition for preventing, postponing or treating ocular diseases and its use
TWI674102B Use of Cordyceps Cicadae mycelia active substance for manufacturing the composition for preventing, postponing or curing changes in the anterior/posterior chamber volume, vitreous humour, and/or retinal detachment
TW202008998A An active substance oflactobacillus plantarum gkm3, a composition comprising thereof and its use for promoting longevity
TW202008996A An active substance of Bifidobacterium lactis GKK2, a composition comprising thereof and its use for promoting longevity
TW202008995A An active substance of Lactobacillus paracasei GKS6, a composition comprising thereof and its use for promoting longevity
TW202008994A A bifidobacterium lactis gkk2, a composition comprising thereof and its use for improving allergic asthma
WO2020006663A1 Novel lactobacillus paracasei gks6 for mitigating metabolic syndrome, culture medium thereof, culture method, use, pharmaceutical composition, and edible composition
TW202003004A Use of antrodia cinnamomea mycelia active substance for ameliorating chronic obstructive pulmonary disease
TWI663980B Application of Cordyceps cicadae active substance for inhibiting and/or reducing allergic reaction for inhibiting allergic activity by extraction from natural plant
TWI664910B Uses of treating, preventing or improving bone diseases by Lactobacillus bacteria, pharmaceutical composition and edible composition thereof
TWI661830B An active substance of Morchella, its use and a composition thereof for improving the reproductive function
TWI648055B Lepista nuda mycelia compositions and preparation methods for inhibiting melanin synthesis
TWI651412B Novellactobacillus paracasei GKS6 for improving metabolic syndromes, its medium, incubation method, use, pharmaceutical composition and edible composition
TWI636134B A Lactobacillus plantarum, composition, culturing method and use of decrease blood lipids, decrease function index, decrease uric acid and/or anti-inflammatory